I agree with your chart analysis. Fundamentals will come into play now to resolve the chart to the upside. Anticipation of uplisting, continuing rapid growth, 2 billionaire hedgefund investors with superlative track records, new products coming on stream.
IMO $150 is the next stop but it will be short lived. We will see 42.50 by the time the uplisting occurs. When it trades on NASDAQ a surge in demand for this new telemedicine future giant will propel price to $3.50 fairly quickly.
This, of course is speculation but speculation with strong factual support.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.